Physician Assistant · New York, NY
NPI
1174950570
Since 2013
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
520 E 70th St, Starr 341
New York, NY, 10021
Phone (646) 962-2064
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$7.6M
890 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Melanie H Bernstein prescribed most often to Medicare patients was Brukinsa (Zanubrutinib), with 298 prescriptions and refills. In total Melanie H Bernstein wrote 890 Medicare prescriptions that cost $7.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Brukinsa Zanubrutinib | 298 | 298 | 44 | $4.2M |
| Venclexta Venetoclax | 76 | 78 | Under 11 | $1.1M |
| Valacyclovir Valacyclovir Hcl | 72 | 106 | 22 | $1,658 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 66 | 91 | 16 | $244 |
| Imbruvica Ibrutinib | 60 | 60 | Under 11 | $982K |
| Calquence Acalabrutinib Maleate | 48 | 48 | Under 11 | $623K |
| Eliquis Apixaban | 25 | 31 | Under 11 | $17K |
| Entecavir Generic | 22 | 24 | Under 11 | $967 |
| Zarxio Filgrastim-Sndz | 15 | 15 | Under 11 | $20K |
| Allopurinol Generic | 14 | 42 | Under 11 | $162 |
| Ondansetron Hcl Generic | 13 | 13 | Under 11 | $101 |
| Lenalidomide Generic | 13 | 13 | Under 11 | $170K |
| Prednisone Generic | 11 | 12 | Under 11 | $40.65 |
| Famotidine Generic | 11 | 18 | Under 11 | $204 |
Brand drugs: 581 claims; generic drugs: - claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Melanie H Bernstein were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.